Skip to main content
. 2019 Mar 14;46(1):75–78. doi: 10.1002/jmd2.12023

Figure 2.

Figure 2

Succinylacetone excretion at increasing plasma NTBC levels. As NTBC blood levels increase, there is no significant difference in the mmol SUAC/mol creatinine excreted above an NTBC plasma level of 40 μmol/L (P > 0.05), supporting a therapeutic range of 40 to 60 μmol/L. There is significant difference in succinylacetone excretion below 40 μmol/L (P < 0.05)